Search

Learn the difference between CT Scan and MRI and how doctors use these imaging techniques to diagnose and stage cancer.

… Wednesday, June 4, 2025 Getting the right diagnosis often starts with the right imaging test, but how do you know which one is right for you? If your doctor has recommended a  CT scan  or an  MRI , you might be wondering what the difference is — and why one might be chosen over the other. Both tests

As part of Memorial Sloan Kettering’s 33rd annual academic convocation on May 11, the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences awarded PhDs to four graduates.

… Friday, May 18, 2012 Summary As part of Memorial Sloan Kettering’s 33rd annual academic convocation on May 11, the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences awarded PhDs to four graduates. Congratulations to the first graduating class of the Louis V. Gerstner, Jr. Graduate School

In honor of his extraordinary contributions to improving the diagnosis and treatment of childhood cancer, Richard O’Reilly, Chairman of the Department of Pediatrics and Director of the Bone Marrow Transplantation Program at MSK, will receive the first Society of Memorial Sloan Kettering Prize.

… Monday, May 2, 2016 In honor of his extraordinary contributions to improving the diagnosis and treatment of childhood cancer, Richard O’Reilly, Chairman of the Department of Pediatrics and Director of the Bone Marrow Transplantation Program at MSK, will receive the first Society of Memorial Sloan Kettering

MSK researchers shared their latest research developments at the 2021 meeting of the American Association for Cancer Research.

… Wednesday, April 14, 2021 Three Memorial Sloan Kettering experts shared important research findings in plenary talks during Week 1 of the American Association for Cancer Research’s (AACR) virtual Annual Meeting 2021, held from April 10 to 15. Two presentations shed light on how genetic mutations lead

The Prospective Registry Of Multi-Plex Testing (PROMPT) - a new online, volunteer registry for individuals who have been tested for inherited mutations in cancer-causing genes - will provide data vital to improving our understanding of newly discovered, cancer-associated genes and allow current and future generations to better interpret and benefit from knowledge of their genomes.

… Tuesday, September 23, 2014 A newly formed consortium including experts from academic medical centers and commercial genetics laboratories across the country has established the Prospective Registry Of Multi-Plex Testing (PROMPT), an online registry for individuals and families who have undergone testing

Learn how MSK is joining forces with the City of New York to expand access to the COVID-19 vaccine.

… Friday, April 9, 2021 Christy Manso/staff, MSK Staff/vaccinators, Christy in the center Memorial Sloan Kettering Community Programs manager Christy Manso addresses MSK vaccinators. Anika Navaroli/non-staff Resident Anika Navaroli snaps a selfie when it’s her turn to get the vaccine. Claudia Derico/staff

Memorial Sloan Kettering (MSK) has reached a major milestone in bringing personalized treatments to more cancer patients. Michael Berger, PhD, Ahmet Zehir, PhD, and colleagues have reported an in-depth analysis of the first 10,336 patients whose tumors were submitted for clinical genomic sequencing by MSK-IMPACT™, a powerful diagnostic test developed at MSK to provide detailed genetic information about a patient’s cancer.

… Monday, May 8, 2017 Memorial Sloan Kettering (MSK) has reached a major milestone in bringing personalized treatments to more cancer patients. Michael Berger, PhD , Ahmet Zehir, PhD, and colleagues have reported an in-depth analysis of the first 10,336 patients whose tumors were submitted for clinical

Chemotherapy after immune checkpoint inhibitors (ICIs) may improve survival rates in patients with heavily pretreated, recurrent ovarian cancer.

… Thursday, September 19, 2019 Chemotherapy after immune checkpoint inhibitors (ICIs) may improve survival rates in patients with heavily pretreated, recurrent ovarian cancer, according to our retrospective review of outcomes for 79 women treated at Memorial Sloan Kettering Cancer Center. Median overall

Molecular biologist Christine Mayr, MD, PhD, of Memorial Sloan Kettering’s (MSK) Sloan Kettering Institute (SKI) is one of 12 2016 recipients of the prestigious National Institutes of Health (NIH) Director’s Pioneer Award. Established in 2004, the annual award recognizes and supports individual scientists of exceptional creativity who propose pioneering and highly innovative approaches with the potential to produce an unusually high impact on biomedical or behavioral research.

… Tuesday, October 4, 2016 Molecular biologist Christine Mayr, MD, PhD , of Memorial Sloan Kettering’s (MSK) Sloan Kettering Institute (SKI) is one of 12 2016 recipients of the prestigious National Institutes of Health (NIH) Director’s Pioneer Award. Established in 2004, the annual award recognizes and

… Friday, June 6, 2025 From the day Shakima Grant was hired as a care coordinator at MSK, in 2007, she says she knew she had found her purpose. “It always felt like I was meant to be here,” says Shakima, whose grandmother passed away from stage 4 ovarian cancer that very same year. Her grandmother lived